Annual Net Income
-$126.64 M
-$33.74 M-36.31%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual net profit is -$126.64 million, with the most recent change of -$33.74 million (-36.31%) on April 30, 2024.
- During the last 3 years, KALV annual net income has fallen by -$80.40 million (-173.86%).
- KALV annual net income is now -6068.73% below its all-time high of -$2.05 million, reached on December 31, 2012.
Performance
KALV Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$42.27 M
-$1.82 M-4.51%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly net profit is -$42.27 million, with the most recent change of -$1.82 million (-4.51%) on October 31, 2024.
- Over the past year, KALV quarterly net income has increased by +$2.38 million (+5.33%).
- KALV quarterly net income is now -6333.49% below its all-time high of -$657.00 thousand, reached on April 30, 2018.
Performance
KALV Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$156.39 M
-$14.62 M-10.31%
October 31, 2024
Summary
- As of February 8, 2025, KALV TTM net profit is -$156.39 million, with the most recent change of -$14.62 million (-10.31%) on October 31, 2024.
- Over the past year, KALV TTM net income has dropped by -$29.74 million (-23.49%).
- KALV TTM net income is now -12856.75% below its all-time high of -$1.21 million, reached on December 31, 2013.
Performance
KALV TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
KALV Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.3% | +5.3% | -23.5% |
| 3 y3 years | -173.9% | -115.1% | -157.4% |
| 5 y5 years | -508.4% | -616.0% | -403.5% |
KALV Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -173.9% | at low | -98.4% | +5.3% | -113.7% | at low |
| 5 y | 5-year | -508.4% | at low | -542.0% | +5.3% | -437.1% | at low |
| alltime | all time | -6068.7% | at low | -6333.5% | +5.3% | <-9999.0% | at low |
KalVista Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$42.27 M(+4.5%) | -$156.39 M(+10.3%) |
| Jul 2024 | - | -$40.44 M(-9.4%) | -$141.77 M(+11.9%) |
| Apr 2024 | -$126.64 M(+36.3%) | -$44.65 M(+53.8%) | -$126.64 M(+16.9%) |
| Jan 2024 | - | -$29.03 M(+5.0%) | -$108.30 M(+7.7%) |
| Oct 2023 | - | -$27.65 M(+9.2%) | -$100.58 M(+5.7%) |
| Jul 2023 | - | -$25.32 M(-3.8%) | -$95.18 M(+2.4%) |
| Apr 2023 | -$92.91 M(+12.8%) | -$26.30 M(+23.5%) | -$92.91 M(+2.4%) |
| Jan 2023 | - | -$21.30 M(-4.3%) | -$90.72 M(-1.3%) |
| Oct 2022 | - | -$22.26 M(-3.4%) | -$91.88 M(+2.9%) |
| Jul 2022 | - | -$23.04 M(-4.4%) | -$89.27 M(+8.4%) |
| Apr 2022 | - | -$24.11 M(+7.3%) | -$82.34 M(+12.5%) |
| Apr 2022 | -$82.34 M(+78.1%) | - | - |
| Jan 2022 | - | -$22.47 M(+14.3%) | -$73.18 M(+20.4%) |
| Oct 2021 | - | -$19.65 M(+22.0%) | -$60.76 M(+17.9%) |
| Jul 2021 | - | -$16.11 M(+7.7%) | -$51.54 M(+11.5%) |
| Apr 2021 | -$46.24 M(+58.8%) | -$14.96 M(+48.8%) | -$46.24 M(+22.1%) |
| Jan 2021 | - | -$10.05 M(-3.6%) | -$37.87 M(+2.0%) |
| Oct 2020 | - | -$10.43 M(-3.6%) | -$37.12 M(+13.9%) |
| Jul 2020 | - | -$10.81 M(+64.2%) | -$32.59 M(+11.9%) |
| Apr 2020 | -$29.12 M(+39.9%) | -$6.58 M(-29.1%) | -$29.12 M(-6.3%) |
| Jan 2020 | - | -$9.29 M(+57.4%) | -$31.06 M(+20.7%) |
| Oct 2019 | - | -$5.90 M(-19.6%) | -$25.72 M(+11.2%) |
| Jul 2019 | - | -$7.34 M(-13.9%) | -$23.12 M(+11.1%) |
| Apr 2019 | -$20.82 M | -$8.53 M(+115.5%) | -$20.82 M(+60.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | -$3.96 M(+19.7%) | -$12.95 M(-9.0%) |
| Oct 2018 | - | -$3.30 M(-34.3%) | -$14.22 M(-10.6%) |
| Jul 2018 | - | -$5.03 M(+665.6%) | -$15.91 M(+0.6%) |
| Apr 2018 | -$15.80 M(-15.0%) | -$657.00 K(-87.4%) | -$15.80 M(-18.3%) |
| Jan 2018 | - | -$5.23 M(+5.0%) | -$19.35 M(-11.1%) |
| Oct 2017 | - | -$4.99 M(+1.2%) | -$21.76 M(+13.6%) |
| Jul 2017 | - | -$4.93 M(+17.3%) | -$19.16 M(-11.2%) |
| Apr 2017 | -$18.60 M(+62.7%) | -$4.20 M(-45.0%) | -$21.58 M(-10.0%) |
| Jan 2017 | - | -$7.64 M(+220.5%) | -$23.99 M(+9.0%) |
| Sep 2016 | - | -$2.38 M(-67.6%) | -$22.00 M(-10.6%) |
| Jun 2016 | - | -$7.35 M(+11.2%) | -$24.61 M(-6.3%) |
| Apr 2016 | -$11.44 M(-54.0%) | - | - |
| Mar 2016 | - | -$6.61 M(+16.8%) | -$26.27 M(+5.7%) |
| Dec 2015 | -$24.85 M(+243.8%) | -$5.66 M(+13.4%) | -$24.85 M(+4.0%) |
| Sep 2015 | - | -$4.99 M(-44.6%) | -$23.90 M(+4.3%) |
| Jun 2015 | - | -$9.01 M(+73.8%) | -$22.91 M(+38.6%) |
| Apr 2015 | -$7.23 M(-45.9%) | - | - |
| Mar 2015 | - | -$5.18 M(+10.0%) | -$16.53 M(+23.7%) |
| Dec 2014 | -$13.36 M(+135.3%) | -$4.71 M(+18.0%) | -$13.36 M(+35.6%) |
| Sep 2014 | - | -$4.00 M(+51.6%) | -$9.85 M(+68.2%) |
| Jun 2014 | - | -$2.63 M(+30.8%) | -$5.86 M(+81.8%) |
| Mar 2014 | - | -$2.02 M(+66.9%) | -$3.22 M(+166.9%) |
| Dec 2013 | -$5.68 M(+176.6%) | -$1.21 M | -$1.21 M |
| Dec 2012 | -$2.05 M | - | - |
FAQ
- What is KalVista Pharmaceuticals annual net profit?
- What is the all time high annual net income for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual net income year-on-year change?
- What is KalVista Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly net income year-on-year change?
- What is KalVista Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals TTM net income year-on-year change?
What is KalVista Pharmaceuticals annual net profit?
The current annual net income of KALV is -$126.64 M
What is the all time high annual net income for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual net profit is -$2.05 M
What is KalVista Pharmaceuticals annual net income year-on-year change?
Over the past year, KALV annual net profit has changed by -$33.74 M (-36.31%)
What is KalVista Pharmaceuticals quarterly net profit?
The current quarterly net income of KALV is -$42.27 M
What is the all time high quarterly net income for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly net profit is -$657.00 K
What is KalVista Pharmaceuticals quarterly net income year-on-year change?
Over the past year, KALV quarterly net profit has changed by +$2.38 M (+5.33%)
What is KalVista Pharmaceuticals TTM net profit?
The current TTM net income of KALV is -$156.39 M
What is the all time high TTM net income for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM net profit is -$1.21 M
What is KalVista Pharmaceuticals TTM net income year-on-year change?
Over the past year, KALV TTM net profit has changed by -$29.74 M (-23.49%)